Market Research Logo

Global Neurostimulation Devices Market - Segmented by Device Type, Application, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)

Global Neurostimulation Devices Market - Segmented by Device Type, Application, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)

The global neurostimulation devices market is expected to register a CAGR of 12.5% during the forecast period of 2018 - 2023. The rise in the technological advancements and innovation with growing geriatric population base is increasing the demand for the need of neurostimulation devices market. The well-established healthcare infrastructure with the high adoption rate of new technologies and innovation in neurological devices, helps North America to dominate the market.

Increasing Prevalence of Neurological Disorders

The rising prevalence of neurological disorders is one of the primary factors driving the neurostimulation devices market. In 2013, as per the National Center for Health Statistics of the Centers for Disease Control and Prevention (CDC), 84,767 people had died due to Alzheimer’s disease. Each year nearly, 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally. In emerging markets such as India, nearly 30 million people suffer from neurological disorders with a prevalence of around 2,400 patients per 10,000 population. Thus, a high number of patients suffering from neurological diseases needs hospitalizations, worldwide, which raises the demand for early diagnosis of these diseases driving this market.

Other factors driving this market are the rising demand for minimally invasive technologies and the expanding number of elderly patients with neurological disorders seeking technological advancements in neurological devices.

High Cost of Neurological Diseases Treatment

Annually, a large part of healthcare expenditure goes to the neurological disease treatment. It is highly expensive for the public in developed countries and more so in the emerging market. Over one-third population of the United States suffer from neurological diseases, which is close to a 100 million, and posts enormous financial strain over the healthcare system, as nearly USD 800 billion annual costs goes into its treatment. In emerging markets such South Asian countries, the financial burden for the treatment of neurological conditions is further misbalanced compared to the patients require the treatment. Thus, it is one of primary factor impeding this market.

Another major factor impeding this market is the lack of skilled healthcare professionals in neurology.

Asia-Pacific Holds Vast Growth Opportunities

The Asia-Pacific region is expected to show fastest growth rate over the period, 2018 to 2023 which should provide huge investment opportunities for the neurostimulation devices companies in countries, such as India, China, and Japan. In recent years, high economic growth has been observed in these countries, with a vast diversified patient pool. These countries have observed an improving healthcare facilities largely due to involvement and expansion of private sectors companies in healthcare collaborating with multinational healthcare organizations to provide better treatment, giving rise to multiple growth prospects.

The North America region is expected to dominate the market in the forecast period due to the well-developed healthcare infrastructure, healthcare facilities, and high adoption of new technologies.

Key Developments in the Market

  • February 2018 - Synergia Medical SA raised EUR 8.1 million in Series A funding for its novel opto-electronic neurostimulation device.
  • January 2018 - Helius Medical Technologies, Inc. partnered with Key Tronic Corp. to manufacture portable neuromodulation stimulator (PoNS).
  • Major players: ABBOTT, BAYER CORPORATION, BOSTON SCIENTIFIC CORPORATION, CYBERONICS, INC., DEPUY SYNTHES, INTERPACE DIAGNOSTICS LLC, NEURONETICS, NEUROPACE, INC., NEVRO CORP, AND SYNAPSE BIOMEDICAL, INC., amongst others.

    Reasons to Purchase the Report
  • Current and future of neurostimulation devices market outlook in the developed and emerging markets.
  • Analysis of various perspectives of the market with the help of Porter’s Five Forces Analysis.
  • The segment that is expected to dominate the market.
  • Regions that are expected to witness the fastest growth during the forecast period.
  • Identify the latest developments, market shares, and strategies employed by the major market players.
  • 3-month analyst support, along with the Market Estimate sheet (in Excel).
  • Customization of the Report

    This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.


    1. Introduction
    1.1 Market Definition
    2. Research Methodology
    3. Executive Summary
    4. Key Inferences
    5. Market Overview
    5.1 Current Market Scenario
    5.2 Porter's Five Forces Analysis
    5.2.1 Bargaining Power of Suppliers
    5.2.2 Bargaining Power of Consumers
    5.2.3 Threat of New Entrants
    5.2.4 Threat of Substitute Products and Services
    5.2.5 Competitive Rivalry
    6. Market Dynamics
    6.1 Drivers
    6.1.1 Rising Prevalence of Neurological Disorders
    6.1.2 Rising Demand of Minimally Invasive Technologies
    6.1.3 Rising Number of Elderly Patients with Neurological Disorders
    6.1.4 Development of Technologically Advanced Neurological Devices
    6.2 Restraints
    6.2.1 High Cost of Neurological Diseases Treatment
    6.2.2 Lack of Skilled Healthcare Professionals in Neurology
    6.3 Opportunities
    6.4 Key Challenges
    7. Market Segmentation
    7.1 By Devices Type
    7.1.1 Implantable Devices
    7.1.1.1 Vagus Nerve Stimulators
    7.1.1.2 Spinal Cord Stimulators
    7.1.1.3 Deep Brain Stimulators
    7.1.1.4 Gastric Electric Stimulators
    7.1.1.5 Others
    7.1.2 External Devices
    7.1.2.1 Transcranial Magnetic Stimulation (TMS)
    7.1.2.2 Transcutaneous Electrical Nerve Stimulation (TENS)
    7.1.2.3 Others
    7.2 By Application
    7.2.1 Parkinson's Disease
    7.2.2 Epilepsy
    7.2.3 Depression
    7.2.4 Dystonia
    7.2.5 Pain Management
    7.2.6 Others Indications
    7.3 By Geography
    7.3.1 North America
    7.3.1.1 United States
    7.3.1.2 Canada
    7.3.1.3 Mexico
    7.3.1.4 Rest of North America
    7.3.2 Europe
    7.3.2.1 France
    7.3.2.2 Germany
    7.3.2.3 United Kingdom
    7.3.2.4 Italy
    7.3.2.5 Spain
    7.3.2.6 Rest of Europe
    7.3.3 Asia-Pacific
    7.3.3.1 China
    7.3.3.2 Japan
    7.3.3.3 India
    7.3.3.4 Australia
    7.3.3.5 South Korea
    7.3.3.6 Rest of Asia-Pacific
    7.3.4 Middle East & Africa
    7.3.4.1 GCC
    7.3.4.2 South Africa
    7.3.4.3 Rest of Middle East & Africa
    7.3.5 South America
    7.3.5.1 Brazil
    7.3.5.2 Argentina
    7.3.5.3 Rest of South America
    8. Competitive Landscape
    8.1 Mergers & Acquisition Analysis
    8.2 Agreements, Collaborations, and Partnerships
    8.3 New Products Launches
    9. Key Players
    9.1 Abbott
    9.2 Bayer Corporation
    9.3 Boston Scientific Corporation
    9.4 Cyberonics, Inc.
    9.5 DePuy Synthes
    9.6 Interpace Diagnostics LLC
    9.7 Neuronetics
    9.8 NeuroPace, Inc.
    9.9 Nevro Corp
    9.10 Synapse Biomedical, Inc.
    *List not Exhaustive
    10. Future of the Market
    11. Disclaimer

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Share this report